Ligand id: 8361

Name: elotuzumab

Immunopharmacology Comments
Elotuzumab targets the CS1 surface glycoprotein that is highly expressed in primary tumor cells from the majority of MM patients [2].
Immunopharmacology Disease
Disease X-Refs Comment References
Systemic lupus erythematosus Disease Ontology: DOID:9074
OMIM: 152700
Orphanet: ORPHA536
CS1 expression is elevated in patients with SLE suggesting that CS1-targeted inhibition may be effective in this condition.
Multiple myeloma Disease Ontology: DOID:9538
OMIM: 254500
Approved drug for MM.